Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. score tier "卓越"、market "China A-shares"、No report yetで絞り込み:60 match(絞り込みを解除)。

# 銘柄 Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin レポート FY
1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760 · 深圳 $27B
95/100 卓越
30.1%low 21.4% 10 yr+ Net cash 64% FY2025
2 Kweichow Moutai Co Ltd 600519 · 上海 $236B
93/100 卓越
30.8%low 22.9% 10 yr+ Net cash 90% FY2025
3 Shenzhen New Industries Biomedical 300832 · 深圳 $5.3B
93/100 卓越
23.5%low 17.4% 10 yr+ Net cash 75% FY2025
4 Proya Cosmetics Co Ltd Class A 603605 · 上海 $3.3B
93/100 卓越
22.1%low 13.8% 10 yr+ Net cash 66% FY2025
5 Foshan Haitian Flavouring and Food Co Ltd 603288 · 上海 $31B
92/100 卓越
26.3%low 17.0% 10 yr+ Net cash 41% FY2025
6 Zhejiang Weixing New Building Materials Co Ltd 002372 · 深圳 $2.0B
92/100 卓越
23.9%low 15.2% 10 yr+ Net cash 43% FY2025
7 Gongniu Group Co Ltd 603195 · 上海 $11B
91/100 卓越
36.5%low 24.2% 10 yr+ Net cash 41% FY2025
8 Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · 上海 $5.0B
91/100 卓越
19.7%low 15.7% 10 yr+ Net cash 74% FY2025
9 Hubei Jumpcan Pharmaceutical Co Ltd 600566 · 上海 $3.4B
91/100 卓越
21.6%low 12.2% 10 yr+ Net cash 83% FY2025
10 Hangzhou Robam Appliances Co Ltd 002508 · 深圳 $2.1B
90/100 卓越
19.8%low 10.9% 10 yr+ Net cash 53% FY2025
11 Yealink Network Technology Corp Ltd 300628 · 深圳 $6.9B
89/100 卓越
28.7%low 20.6% 10 yr+ Net cash 67% FY2025
12 Midea Group Co Ltd 000333 · 深圳 $94B
88/100 卓越
22.1%low 17.8% 10 yr+ Net cash 26% FY2025
13 Hangzhou Hikvision Digital Technology Co Ltd 002415 · 深圳 $48B
88/100 卓越
23.9%low 14.8% 10 yr+ Net cash 49% FY2025
14 Inner Mongolia Yili Industrial Group Co Ltd 600887 · 上海 $24B
88/100 卓越
21.5%low 15.9% 10 yr+ Net cash 34% FY2025
15 Zhangzhou Pientzehuang Pharmaceutical Co Ltd 600436 · 上海 $12B
88/100 卓越
20.3%low 14.8% 10 yr+ Net cash 44% FY2025
16 Anhui Gujing Distillery Co Ltd 000596 · 深圳 $7.0B
88/100 卓越
18.6%low 13.9% 10 yr+ Net cash 77% FY2025
17 CoCreation Grass Co Ltd 605099 · 上海 $1.9B
88/100 卓越
27.8%low 17.3% 10 yr+ Net cash 33% FY2025
18 Gree Electric Appliances Inc of Zhuhai 000651 · 深圳 $33B
87/100 卓越
24.9%low 19.3% 10 yr+ Net cash 29% FY2025
19 Hithink RoyalFlush Info Network 300033 · 深圳 $25B
87/100 卓越
26.7%low 19.0% 10 yr+ Net cash 90% FY2025
20 Eastroc Beverage Group Co Ltd 605499 · 上海 $14B
87/100 卓越
34.5%low 19.9% 9 yr Net cash 45% FY2025
21 Henan Shuanghui Investment & Development Co Ltd 000895 · 深圳 $13B
87/100 卓越
27.6%low 21.3% 10 yr+ Net cash 17% FY2025
22 Anker Innovations Technology Co Ltd 300866 · 深圳 $10B
87/100 卓越
26.6%low 15.9% 10 yr+ Net cash 45% FY2025
23 Anhui Yingjia Distillery Co Ltd 603198 · 上海 $4.4B
87/100 卓越
21.0%low 16.2% 10 yr+ Net cash 66% FY2025
24 HLA GROUP CORP LTD 600398 · 上海 $4.2B
87/100 卓越
19.8%low 11.8% 10 yr+ Net cash 39% FY2025
25 Henan Lingrui Pharmaceutical Co Ltd 600285 · 上海 $1.8B
87/100 卓越
16.6%low 10.0% 10 yr+ Net cash 74% FY2025
26 Shanxi Xinghuacun Fen Wine Factory Co Ltd 600809 · 上海 $22B
86/100 卓越
29.0%low 12.7% 10 yr+ Net cash 72% FY2025
27 Aier Eye Hospital Group 300015 · 深圳 $12B
86/100 卓越
17.4%low 14.2% 10 yr+ Net cash 49% FY2025
28 Hebei Yangyuan ZhiHui Beverage Co Ltd 603156 · 上海 $6.8B
86/100 卓越
21.0%low 12.8% 10 yr+ Net cash 48% FY2025
29 Zhejiang Supor Co Ltd 002032 · 深圳 $4.8B
86/100 卓越
28.8%low 23.7% 10 yr+ Net cash 26% FY2025
30 Xiamen Faratronic Co Ltd 600563 · 上海 $4.3B
86/100 卓越
20.2%low 17.3% 10 yr+ Net cash 39% FY2025
31 Livzon Pharmaceutical Group Inc 000513 · 深圳 $3.9B
86/100 卓越
16.0%low 10.2% 10 yr+ Net cash 63% FY2025
32 Shanghai M&G Stationery Inc 603899 · 上海 $3.0B
86/100 卓越
20.8%low 14.1% 10 yr+ Net cash 23% FY2025
33 Shanghai Flyco Electrical Appliance Co Ltd 603868 · 上海 $1.9B
86/100 卓越
25.0%low 15.1% 10 yr+ Net cash 46% FY2025
34 G-bits Network Technology Xiamen Co Ltd 603444 · 上海 $3.9B
84/100 卓越
28.1%low 19.3% 10 yr+ Net cash 90% FY2025
35 Jiangzhong Pharmaceutical Co Ltd 600750 · 上海 $2.3B
84/100 卓越
15.8%low 12.2% 10 yr+ Net cash 66% FY2025
36 Jafron Biomedical Co Ltd 300529 · 深圳 $2.1B
84/100 卓越
23.3%low 13.9% 10 yr+ Net cash 83% FY2025
37 Jiangsu Hengrui Medicine Co Ltd 600276 · 上海 $50B
83/100 卓越
16.5%low 10.3% 10 yr+ Net cash 86% FY2025
38 Luzhou Lao Jiao Co Ltd 000568 · 深圳 $19B
83/100 卓越
24.6%low 16.9% 10 yr+ Net cash 81% FY2025
39 Huadong Medicine Co Ltd 000963 · 深圳 $7.1B
83/100 卓越
17.6%low 13.5% 10 yr+ Net cash 30% FY2025
40 Lao Feng Xiang Co Ltd A 600612 · 上海 $2.6B
83/100 卓越
18.4%low 11.6% 10 yr+ Net cash 8% FY2025
41 Foxconn Industrial Internet Co Ltd 601138 · 上海 $158B
82/100 卓越
22.0%low 15.0% 10 yr+ Net cash 8% FY2025
42 Suzhou TFC Optical Communication Co Ltd 300394 · 深圳 $26B
82/100 卓越
19.9%low 12.7% 10 yr+ Net cash 53% FY2025
43 Avic Shenyang Aircraft Co Ltd 600760 · 上海 $17B
82/100 卓越
19.2%low 9.5% 10 yr+ Net cash 10% FY2025
44 Shandong Himile Mechanical Science & Technology Co Ltd 002595 · 深圳 $8.5B
82/100 卓越
18.1%low 16.2% 10 yr+ Net cash 33% FY2025
45 Chongqing Brewery Co Ltd 600132 · 上海 $3.1B
82/100 卓越
49.8%low 14.7% 10 yr+ Net cash 46% FY2025
46 Dashenlin Pharm Grp Co Ltd 603233 · 上海 $3.0B
82/100 卓越
18.2%low 13.3% 10 yr+ 0.0× 38% FY2025
47 MicroPort Endovascular MedTech Ltd 688016 · 上海 $1.6B
82/100 卓越
22.2%low 12.8% 10 yr+ Net cash 79% FY2025
48 Yindu Kitchen Equipment Co Ltd 603277 · 上海 $937M
82/100 卓越
18.3%low 12.7% 10 yr+ Net cash 41% FY2025
49 NARI Technology Co Ltd 600406 · 上海 $27B
81/100 卓越
15.3%low 14.2% 10 yr+ Net cash 27% FY2025
50 Shanghai Friendess Electronics Tech 688188 · 上海 $5.9B
81/100 卓越
27.3%low 11.2% 10 yr+ Net cash 82% FY2025
51 Huali Industrial Group Company Limited 300979 · 深圳 $5.8B
81/100 卓越
30.9%low 19.7% 9 yr Net cash 23% FY2025
52 Hisense Kelon Electrical Holdings Co Ltd 000921 · 深圳 $5.3B
81/100 卓越
19.1%low 9.4% 10 yr+ Net cash 21% FY2025
53 Shanghai Huace Navigation Technology Ltd 300627 · 深圳 $3.2B
81/100 卓越
17.0%low 12.2% 10 yr+ Net cash 60% FY2025
54 AIMA Technology Group Co Ltd 603529 · 上海 $2.7B
81/100 卓越
25.4%low 13.3% 10 yr+ Net cash 15% FY2025
55 Opple Lighting Co Ltd 603515 · 上海 $1.8B
81/100 卓越
15.8%low 12.9% 10 yr+ Net cash 37% FY2025
56 Warom Technology Inc Co 603855 · 上海 $794M
81/100 卓越
16.7%low 8.9% 10 yr+ Net cash 51% FY2025
57 Runner Xiamen Corp 603408 · 上海 $650M
81/100 卓越
20.1%low 12.8% 10 yr+ Net cash 26% FY2025
58 China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999 · 深圳 $6.0B
80/100 卓越
14.4%low 11.6% 10 yr+ Net cash 60% FY2025
59 Jiangsu Nhwa Pharmaceutical Co Ltd 002262 · 深圳 $3.1B
80/100 卓越
16.2%low 13.1% 10 yr+ Net cash 66% FY2025
60 Dalian Bio-Chem Co Ltd 603360 · 上海 $1.2B
80/100 卓越
21.2%low 14.6% 10 yr+ Net cash 48% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.